Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. - Wikidata - awgldk - TriplyDB

Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology.

Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology.

http://www.wikidata.org/entity/Q36292232

about

Basic fibroblast growth factor and vascular endothelial growth factor serum levels in breast cancer patients and healthy women: useful as diagnostic tools?Application of platelet-rich plasma with stem cells in bone and periodontal tissue engineering The effect of pre-analytical variability on the measurement of MRM-MS-based mid- to high-abundance plasma protein biomarkers and a panel of cytokines Predictive and prognostic angiogenic markers in a gynecologic oncology group phase II trial of bevacizumab in recurrent and persistent ovarian or peritoneal cancer.Highly accumulated platelet vascular endothelial growth factor in coagulant thrombotic region.Renal involvement of thrombotic thrombocytopenic purpura: special reference to the glomeruloid structures.Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage Platelets actively sequester angiogenesis regulators.NF-E2 p45 is important for establishing normal function of platelets.Presence of intratumoral platelets is associated with tumor vessel structure and metastasis Recent advances in the pathobiology and management of Kasabach-Merritt phenomenon.Pancreatic head carcinoma and vascular endothelial growth factor (VEGF-A) concentration in portal blood: its association with cancer grade, tumor size and probably poor prognosis Plasma vascular endothelial growth factor 165 in advanced non-small cell lung cancer Hydrogel and Platelet-Rich Plasma Combined Treatment to Accelerate Wound Healing in a Nude Mouse Model.Serum-dependence of affinity-mediated VEGF release from biomimetic microspheres Prognostic impact of blood and urinary angiogenic factor levels at diagnosis and during treatment in patients with osteosarcoma: a prospective study.Measurement of cytokines in clinical samples using immunoassays: problems and pitfalls.Vascular endothelial growth factor in the circulation in cancer patients may not be a relevant biomarker Current status of antiangiogenic factors.Comparison of EGF with VEGF non-viral gene therapy for cutaneous wound healing of streptozotocin diabetic mice Essential roles of EphB receptors and EphrinB ligands in endothelial cell function and angiogenesis.Vascular endothelial growth factor in ovarian cancer.Implanted cell-dense prevascularized tissues develop functional vasculature that supports reoxygenation after thrombosis.Lower circulating platelet counts and antiplatelet therapy independently predict better outcomes in patients with head and neck squamous cell carcinoma.Dose-finding study and pharmacogenomic analysis of fixed-rate infusion of gemcitabine, irinotecan and bevacizumab in pretreated metastatic colorectal cancer patients The hemostatic system and angiogenesis in malignancy.A new technique of ex vivo gene delivery of VEGF to wounds using genetically modified skin particles promotes wound angiogenesis.The role of platelets in the pathophysiology of asthma.Platelet activation determines angiopoietin-1 and VEGF levels in malaria: implications for their use as biomarkers Vascular endothelial growth factor and placenta growth factor in intrauterine growth-restricted fetuses and neonates.Measuring carbonic anhydrase IX as a hypoxia biomarker: differences in concentrations in serum and plasma using a commercial enzyme-linked immunosorbent assay due to influences of metal ions.Clinical relevance of serum vascular endothelial growth factor and interleukin-6 in patients with colorectal cancer.Predicting treatment responses and disease progression in myeloma using serum vascular endothelial growth factor and hepatocyte growth factor levels.Prospective evaluation of plasma levels of ANGPT2, TuM2PK, and VEGF in patients with renal cell carcinoma.Prognostic Significance of Combination of Preoperative Platelet Count and Neutrophil-Lymphocyte Ratio (COP-NLR) in Patients with Non-Small Cell Lung Cancer: Based on a Large Cohort Study.Thrombogenesis, atherogenesis and angiogenesis in vascular disease: a new 'vascular triad'.Vascular endothelial growth factor in esophageal cancer.Association of gene polymorphism with serum levels of inflammatory and angiogenic factors in Pakistani patients with age-related macular degeneration.Circulating TGF-β1 and VEGF and risk of cancer among liver transplant recipients.Serum and plasma determination of angiogenic and anti-angiogenic factors yield different results: the need for standardization in clinical practice.

P2860

Q24804008-BCEF60AD-D142-4869-8565-B6A6E20C1A2B Q28076740-B5B1D1C2-8CCD-46B7-A01E-56CBC0C1B7EA Q28484137-AF60D3FF-E631-4795-BD2A-E66C0A43311B Q30497303-29AD1911-AAB9-4198-B02C-F6812B4DAC60 Q33195948-665669F3-050C-49A5-9BBB-9689844B8887 Q33330172-1249F4CE-270D-4ED9-89D5-E46E3E1D318F Q33369958-9940758A-D349-46A8-BEF9-DD29395F3BCC Q33387520-DBD6E578-F1EC-44F8-8554-04D9B7304E4C Q33407515-6D77DEA6-EB6E-48EE-AC93-016355F1963D Q33413771-C7D5C302-FB4C-4572-BA6D-7C54531FA6F0 Q33423967-F734C9A7-88C4-45D7-A8E0-A45594E065A0 Q33701287-F1352663-02E6-4F58-85B8-053754CCEB91 Q33727536-849914F6-85CA-46EB-B20D-C0DAA5C71664 Q33736112-1B2DD877-0516-4C3E-9D8F-2E912C71C0E0 Q33761778-B1F2CE0D-18AE-4F90-A1BB-0C40F3EFB8C3 Q33805555-6894A402-A1B0-42F7-B74B-C20BC62327A5 Q33918736-9800821D-F323-45E1-90B3-3CF9920583E9 Q33920807-C5BC8AF6-C69B-47F5-B83D-795EA15E3D80 Q33962049-1FC437F1-D353-41D8-ABCC-B01FD0A2E683 Q33970018-84649568-6563-4D29-99F6-173B85018872 Q34031959-1DA4012D-7F20-4F6A-9292-D0E4AEEE1722 Q34107669-44F375BC-93A4-47E2-9515-6EB6C746DDE2 Q34164871-7011DC8F-8502-4F9F-9639-00B725490873 Q34306349-CEEEF81F-1CAF-41AF-ABE6-1BE4BFE3619E Q34343973-C02A20B7-4185-4EF2-97F9-E02DADBBEEC9 Q34425462-0113987F-0405-497D-B30D-B872F149C8CE Q34630772-41D5AEDE-4A59-4A38-8BBB-96CAB72835C0 Q34656136-EF503A92-C280-46E1-A19B-2429E92DE5B3 Q34765904-BEA67FB2-120D-4A78-9734-01C5F010E448 Q34945371-978DC01D-4052-4B30-95B5-C631FCDD306A Q35015917-8429378F-4846-44E1-B87E-661F3512AADB Q35064906-2DE9E53A-659A-4685-93AB-605F0C5BA9B4 Q35210404-3592C06B-C88B-4F38-A14E-187F06A4EE98 Q35544474-85BB9E5F-DCE5-46CF-98B4-5617F292CA53 Q35581934-17926999-19D2-4CBB-8DA7-E117B340183F Q35761317-436FEA80-CFB6-430D-9763-660899C14F84 Q35849980-74D2FD15-F86B-475D-82C6-3B1F5F9A5467 Q36003675-FE7B3FD4-72DD-4733-A797-918D5938541F Q36023899-AD87B9B3-1C9D-43E1-9A86-F8CC3BFAF3CC Q36185056-2DE087CC-9EBF-4148-AE59-BF59F550FC0A

P2860

Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology.

http://www.wikidata.org/entity/Q36292232

description

1998 nî lūn-bûn

@nan

1998年の論文

@ja

1998年学术文章

@wuu

1998年学术文章

@zh-cn

1998年学术文章

@zh-hans

1998年学术文章

@zh-my

1998年学术文章

@zh-sg

1998年學術文章

@yue

1998年學術文章

@zh

1998年學術文章

@zh-hant

name

Release of the angiogenic cyto ...... asurements and cancer biology.

@ast

Release of the angiogenic cyto ...... asurements and cancer biology.

@en

type

label

Release of the angiogenic cyto ...... asurements and cancer biology.

@ast

Release of the angiogenic cyto ...... asurements and cancer biology.

@en

prefLabel

Release of the angiogenic cyto ...... asurements and cancer biology.

@ast

Release of the angiogenic cyto ...... asurements and cancer biology.

@en

P1433

Q36292232-A765F0FB-60A1-4945-ADC3-FEF35D8A1700

P1476

Q36292232-B656E7D3-9C69-40D4-973E-EC35DB392296

P2093

Q36292232-282B4E8D-007E-425E-ACAC-73FAC1308145

Q36292232-4FBBEA80-55BD-4100-B0E2-C168D5FBF842

Q36292232-57250526-4383-423A-98AD-03B6ED982CCA

Q36292232-6915A9EC-C159-412B-9297-8FB8669448FA

Q36292232-B416098F-13B1-4F5F-BD83-EC6897496511

Q36292232-FB8E8AFE-3703-4536-AE89-5AC91FE54AAC

P2860

Q36292232-053E2ED3-EAC1-437E-B12D-7EF761816034

Q36292232-0698E54B-2401-4B52-92D6-F8AF938C6DD6

Q36292232-0A98FA85-2FB3-4D5A-A893-E4F80740D48C

Q36292232-0FFDDC38-DB05-40FC-A729-23D4D406FAB2

Q36292232-123D021E-52D8-4E44-9FA3-D2D7E670A1C6

Q36292232-1565BE08-DEFE-4C12-93CA-4003CACA8489

Q36292232-1827BFD4-B64E-4781-ACF3-BEA9D3F7FAD9

Q36292232-26F25CF8-366F-4D13-AB93-2972DD949E10

Q36292232-2A5735CC-F5A0-4091-9F52-A13275E73D48

Q36292232-2C07D9B2-6CAE-4BAE-B196-9208D3487627

P2888

Q36292232-A2B002E3-3BE6-4404-9D3C-64A3A99AF4DA

P304

Q36292232-AF0A9C05-442B-4F38-8525-AF9F2CBA4F4C

P31

Q36292232-18D45C67-05D8-4F1D-8EE9-B5C97B027DDD

P356

Q36292232-EA792CAF-781E-424E-AA50-5C1F9F5802FD

P407

Q36292232-62CE2C62-EB4B-4840-BDE6-D29B60A92F26

P433

Q36292232-CB8E22FB-E4B3-4262-82FD-E6F9B06299DD

P478

Q36292232-984B7213-104C-440D-86A3-44363863AD56

P50

Q36292232-A83C55D3-4DF8-40CA-877A-F39BD8961B9F

P577

Q36292232-A5C837D6-7166-4B9E-9960-0B883676774F

P5875

Q36292232-398CDB50-8033-43B2-8142-0853D7497FF9

P698

Q36292232-AE58FB51-E215-4B40-9FE6-69B752A0F615

P921

Q36292232-3C004506-1447-47D1-AAD6-5A4EF5706432

P932

Q36292232-04A965C0-6C8E-4980-8414-F0A3C6D4203E

P356

P1433

British Journal of Cancer

P1476

Release of the angiogenic cyto ...... easurements and cancer biology

@en

P2093

A Stanley

http://www.w3.org/2001/XMLSchema#string

C Walters

http://www.w3.org/2001/XMLSchema#string

E Ingham

http://www.w3.org/2001/XMLSchema#string

M A Forbes

http://www.w3.org/2001/XMLSchema#string

P J Selby

http://www.w3.org/2001/XMLSchema#string

S E Kinsey

http://www.w3.org/2001/XMLSchema#string

P2860

Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family

Vascular endothelial growth factor B, a novel growth factor for endothelial cells

Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor

Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1

The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor

A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases

Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor

Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis

Identification of a new endothelial cell growth factor receptor tyrosine kinase

A heparin-binding form of placenta growth factor (PlGF-2) is expressed in human umbilical vein endothelial cells and in placenta

P2888

P304

956-964

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.1998.158

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

77

http://www.w3.org/2001/XMLSchema#string

P50

Rosamonde Elizabeth Banks

P577

1998-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51321299

http://www.w3.org/2001/XMLSchema#string

P698

9528841

http://www.w3.org/2001/XMLSchema#string

P921

P932

2150108

http://www.w3.org/2001/XMLSchema#string